Navigation Links
IPRO Alerts New Yorkers to 'Silent' Killer; Chronic Kidney Disease Doubling Every Ten Years
Date:3/9/2009

LAKE SUCCESS, N.Y., March 9 /PRNewswire-USNewswire/ -- Chronic Kidney Disease (CKD), which affects 20 million people, is now the ninth leading cause of death in the U.S. and it is growing at a steady and alarming rate -- doubling every ten years. Each year the cost of managing CKD exceeds $32 billion in public and private spending. African Americans and Hispanic Americans are at increased risk for developing CKD and kidney failure.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080725/DC28791LOGO)

IPRO, New York's Medicare-funded Quality Improvement Organization (QIO), is working to improve care for Medicare beneficiaries with CKD and urging at-risk New Yorkers to be tested. Diabetes is the leading cause of kidney disease and kidney failure, both of which are very serious conditions that can lead to complications and death. People who have high blood pressure are also at risk for CKD. It is estimated that more than one million New Yorkers suffer from CKD.

"March is National Kidney month: a perfect time to call attention to the fact that most people who have kidney disease don't know it," according to IPRO Chief Medical Officer Clare Bradley, MD, MPH. She explained that most people do not have outward symptoms in the early phase of the disease. In fact, many do not have any obvious symptoms like hypertension or diabetes. This is called the "silent phase" of the disease. "The only way to know if you have CKD is to get some simple medical tests," says Dr. Bradley. She urges people with diabetes and/or high blood pressure to ask their doctor about these tests:

  • Blood pressure check,
  • Urine Test (micro-albumin),
  • Blood test (with eGFR - estimated glomerular filtration rate).

"If you do not have a doctor you see regularly, you should look for free kidney screenings in your community," according to Dr. Bradley. The local chapter of the National Kidney Foundation provides screening in many communities.

Managing diabetes helps protect kidneys. Diabetes management includes monitoring blood glucose according to the recommended schedule and monitoring blood pressure. "It is very important to get your kidneys checked at least once a year," Dr. Bradley explains. "This message of early detection and management of CKD is important in improving clinical outcomes and avoiding additional costly expenditures."

The Centers for Medicare & Medicaid Services (CMS) is funding and coordinating a pilot CKD quality improvement effort in New York and nine other states as well as in the U.S. Virgin Islands. Over 150 physicians are working in New York to implement system changes to greatly improve the quality of CKD management. These physicians are enhancing quality of life for their patients, reducing death rates, and saving health care dollars by preserving kidney health.


'/>"/>
SOURCE IPRO
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Beacon Equity Issues Technical Trade Alerts on Healthcare Plan Stocks: HUM, WLP, AET, CI, UNH, UAM
2. Stop & Shop Alerts Customers to Voluntary Recall by Northern Star Company
3. Beacon Equity Issues Technical Trade Alerts on Drug Manufacturers: JNJ, ABT, LLY, PFE, NVS, GSK
4. Technical Trade Alerts on BeaconEquity OTC Gainers: UVSE, GETG, SRCH, GFET, YTBLA, NTRZ
5. Clinicians override most electronic medication safety alerts
6. EPA Alerts Seniors to Carbon Monoxide Dangers
7. Beacon Equity Issues Technical Trade Alerts on Headline Stocks: LLY, PCS, CAG, FRX, TGT, DOW
8. One Million Americans Now Receive Personalized FDA Drug Safety Alerts Through iGuard.org
9. Beacon Equity Issues Technical Trade Alerts on REIT Healthcare Facilities: HCP, HR, VTR, UHT, NHP, NHI
10. Beacon Equity Issues Technical Trade Alerts on Recent Analyst Upgrades: SPC, WSM, MRX, WXS, MHGC, DSPG
11. Beacon Equity Issues Technical Trade Alerts on Recent Analyst Upgrades: WMT, EYE, ESRX, EXP, QLGC, NSM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, M.D., ... From Not to Hot,” which will begin airing on February 24, 2017. The show ... from the 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier series ...
(Date:2/23/2017)... ... February 23, 2017 , ... On April 13, ... symposium on “Doping in Sport: How the Culture Might Change,” in ... LLP. The symposium will be held at Pepperdine University in Malibu, California. , ...
(Date:2/23/2017)... ... 2017 , ... Current Meditation , a new meditation ... the U.S. starting this spring. Current Meditation focuses on “meditation for the modern ... Meditation will be the first meditation concept in the U.S. offering franchising opportunities, ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... CALNOC, the ... FACMPE, FACPE, will keynote their upcoming conference – Empowerment, Value and Collaboration – in ... chairman and CEO of the Virginia Mason Health System in Seattle since 2000. In ...
(Date:2/23/2017)... ... 2017 , ... Thomas Vas-Don suffered from severe injury due to ... able to successfully recover. In “ Origin & Insertion Charts for Massage Therapists ” ... principals of massage, anatomy , trigger points and referral pain patterns . ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017 ... gives comprehensive insights on the various drugs ... The report covers all the drugs that ... Preclinical & Clinical). The pipeline focuses on ... small molecules, antibodies, stem cell therapies, recombinant ...
(Date:2/24/2017)... STOCKHOLM , Feb 24, 2017 ... Nomination Committee,s proposal for a new Board of Directors ... Meeting. The 2016-2017 Nomination Committee comprises representatives of the ... third quarter of 2016 who have accepted a seat ... Board. The composition of the 2016-2017 Nomination Committee was ...
(Date:2/24/2017)... 2017 Research and Markets has announced the ... - 2016" report to their offering. ... The latest research Urinary Incontinence Drugs ... benchmarks in the global Urinary Incontinence market. The research answers ... key drugs marketed for Urinary Incontinence and their clinical attributes? How ...
Breaking Medicine Technology: